Trials / Completed
CompletedNCT04267068
Single Session Intervention to Prevent Common Mental Disorders and Among College Students
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 375 (actual)
- Sponsor
- University of Nevada, Reno · Academic / Other
- Sex
- All
- Age
- 17 Years – 26 Years
- Healthy volunteers
- Accepted
Summary
The present study aims to determine the effect of presenting psychoeducation emphasizing "growth-mindset," and information on depression and anxiety symptom severity. The investigators hypothesize that psychoeducation emphasizing that mental health is malleable will increase the participant's engagement with risk factors outlined in the intervention
Detailed description
Depression and anxiety disorders (or common mental disorders; CMDs) are increasingly common among college students, with rates comparable to the general population. As such, brief, scalable and transdiagnostic prevention efforts targeting CMDs are needed. In order to address this need, this study aims to evaluate the impact of a single session intervention (SSI) utilizing growth mindset (GM) on CMD symptom severity and investigate the mediating role of changes in modifiable risk factors in the relationship between intervention and CMD symptom reduction. The intervention will adapt existing GM interventions for college students to engage mechanisms in the prevention and management of common mental disorders including engagement in modifiable risk factors. College students will be randomly assigned to complete either a GM intervention or a psychoeducation control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Growth Mindset and Modifiable Risk Factor Information | 15 minute interactive article describing neuroplasticity followed by 15 minute interactive article describing modifiable risk factors for depression and anxiety |
| BEHAVIORAL | Control | 30 minute interactive article describing symptoms of depression and anxiety, common concerns of college student |
Timeline
- Start date
- 2019-08-05
- Primary completion
- 2020-07-13
- Completion
- 2020-07-13
- First posted
- 2020-02-12
- Last updated
- 2020-11-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04267068. Inclusion in this directory is not an endorsement.